Business Context and Reporting Period
This Form 8-K, dated July 5, 2022, reports the completion of the merger between Mativ Holdings, Inc. (formerly Schweitzer-Mauduit International, Inc.) and Neenah, Inc. The merger became effective on July 6, 2022, with Neenah surviving as a wholly owned subsidiary of Mativ. Concurrently, the company officially changed its name from Schweitzer-Mauduit International, Inc. to Mativ Holdings, Inc.
Key Financial Metrics and Capital Structure
- Financing: Mativ borrowed $650 million under the delayed draw term loan facility of its existing credit agreement on July 5, 2022.
- Use of Proceeds: Funds were used to repay existing indebtedness of Neenah and to pay costs and expenses associated with the merger.
- Debt Repayment: All indebtedness under Neenah's Fourth Amended and Restated Credit Agreement (dated December 10, 2018) and Amended and Restated Term Loan Credit Agreement (dated April 6, 2021) was repaid.
- Exchange Ratio: Neenah shareholders received 1.358 shares of Mativ common stock for each share of Neenah common stock held.
- Revenue and Profit: The filing text does not provide specific revenue, profit, cash flow, or margin figures for the reporting period.
Material Changes
- Corporate Structure: Neenah is now a wholly owned subsidiary of Mativ.
- Leadership Transition: Dr. Jeffrey Kramer resigned as Chief Executive Officer. Julie A. Schertell was appointed President and CEO, and Omar Hoek was appointed Chief Operating Officer.
- Board Composition: The Board of Directors was reconstituted to nine members, comprising five continuing Mativ directors and four former Neenah directors. Three former Mativ directors (Deborah Borg, Mark Bye, and Jeffrey Kramer) resigned.
- Governance: The company's Certificate of Incorporation and Bylaws were amended to reflect the merger, including specific provisions regarding board vacancies and CEO removal requiring a 75% vote until the 2025 annual meeting.
Outlook, Risks, and Unusual Items
- Executive Transition: Dr. Kramer entered into a Transition Services Agreement to serve as a strategic advisor to the new CEO for one year (July 6, 2022, through July 5, 2023). He will receive a monthly fee of $166,666.67, plus severance benefits and accelerated equity treatment.
- Contingent Obligations: Neenah and certain subsidiaries became guarantors under Mativ's Credit Agreement.
- Management Commentary: The filing does not contain forward-looking financial guidance or specific management commentary on future operational performance beyond the completion of the merger.
Investor Verification Checklist
- Verify the final share count and dilution impact resulting from the 1.358 exchange ratio.
- Review the full text of the Transition Services Agreement (Exhibit 10.1) to understand the total compensation and obligations related to Dr. Kramer's departure.
- Examine the Amended and Restated Bylaws (Exhibit 3.2) for details on the 75% voting threshold required for CEO removal and board amendments until 2025.
- Confirm the terms of the $650 million delayed draw term loan and the remaining capacity under the Credit Agreement.
- Assess the integration plan and synergies expected from combining Mativ and Neenah, as detailed in the joint press release (Exhibit 99.1).